Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Alpha Cognition Inc. (ACOGF : OTC)
 
 • Company Description   
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.50 Daily Weekly Monthly
20 Day Moving Average: 7,350 shares
Shares Outstanding: 44.89 (millions)
Market Capitalization: $22.45 (millions)
Beta:
52 Week High: $1.72
52 Week Low: $0.49
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -36.55% -30.47%
12 Week -37.93% -32.65%
Year To Date -49.49% -39.94%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1228 Hamilton Street Suite 301
-
Vancouver,BC V6B 6L2
CAN
ph: 604-564-9244
fax: -
stefan@bristolir.com http://www.alphacognition.com
 
 • General Corporate Information   
Officers
Michael McFadden - Chief Executive Officer
Len Mertz - Chairman
Fred Sancilio - President and Director
Jeremy Wright - Chief Financial Officer
John Havens - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 02074J204
SIC: -
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 05/27/22
Share - Related Items
Shares Outstanding: 44.89
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $22.45 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.20 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 15.78
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 22.22%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -279.00
09/30/21 - -244.50
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 5.73
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 5.73
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - 0.03
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - 0.72
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - 41.79
 

Powered by Zacks Investment Research ©